Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Lancet (London, England)"
topic_facet:"B5S3K2V0G8"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22B5S3K2V0G8%22&lookfor=%22COVID19%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22B5S3K2V0G8%22&lookfor=%22COVID19%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22B5S3K2V0G8%22&lookfor=%22COVID19%22&type=Subject
PubPharm (31)
1
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters : pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
enthalten in:
Lancet (London, England)
| 2022
von
Agrawal, U.
|
Bedston, S.
|
McCowan, C.
| +24
CommentIn: Lancet. 2022 Oct 15;400(10360):1282-1283. - PMID 36244366
Wird geladen...
2
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years : a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
enthalten in:
Lancet (London, England)
| 2022
von
Li, G.
|
Cappuccini, F.
|
Marchevsky, N.
| +70
CommentIn: Lancet. 2022 Jun 11;399(10342):2171-2173. - PMID 35691308
Wird geladen...
3
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine : a retrospective, total population cohort study in Sweden
enthalten in:
Lancet (London, England)
| 2022
von
Nordström, P.
|
Ballin, M.
|
Nordström, A.
CommentIn: Virol J. 2022 Jun 5;19(1):100. - PMID 35659687
Wird geladen...
4
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
enthalten in:
Lancet (London, England)
| 2022
von
Kuhlmann, C.
|
Mayer, C.
|
Claassen, M.
| +8
ErratumIn: Lancet. 2022 Feb 12;399(10325):628. - PMID 35151396
Wird geladen...
5
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001) : a phase 4, non-inferiority, single blind, randomised study
enthalten in:
Lancet (London, England)
| 2022
von
Costa Clemens, S.
|
Weckx, L.
|
Clemens, R.
| +44
CommentIn: Lancet. 2022 Feb 5;399(10324):496-497. - PMID 35074137
Wird geladen...
6
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2) : a single-blind, randomised, phase 2, non-inferiority trial
enthalten in:
Lancet (London, England)
| 2022
von
Stuart, A.
|
Shaw, R.
|
Liu, X.
| +41
CommentIn: Lancet. 2022 Jan 1;399(10319):3-5. - PMID 34883051
Wird geladen...
7
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time : a retrospective, population-based cohort study in Scotland and Brazil
enthalten in:
Lancet (London, England)
| 2022
von
Katikireddi, S.
|
Cerqueira-Silva, T.
|
Vasileiou, E.
| +21
CommentIn: Lancet. 2022 Jan 1;399(10319):2-3. - PMID 34942104
Wird geladen...
8
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002) : a single-blind, randomised, controlled, phase 2/3 trial
enthalten in:
Lancet (London, England)
| 2021
von
Ramasamy, M.
|
Minassian, A.
|
Ewer, K.
| +162
ErratumIn: Lancet. 2021 Dec 19;396(10267):1978. - PMID 33341142
Wird geladen...
9
Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? - Authors' reply
enthalten in:
Lancet (London, England)
| 2021
von
Bhuyan, P.
|
Medin, J.
|
da Silva, H.
| +2
CommentOn: Lancet. 2021 Nov 13;398(10313):1801. - PMID 34774143
Wird geladen...
10
Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine?
enthalten in:
Lancet (London, England)
| 2021
von
Pavord, S.
|
Scully, M.
|
Lester, W.
| +2
CommentOn: Lancet. 2021 Aug 14;398(10300):577-578. - PMID 34329583
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Lancet (London, England)
Filter aufheben
Thema: B5S3K2V0G8
Medienart
31
Aufsätze
31
E-Artikel
31
E-Ressourcen
Zeitschriftentitel
Lancet (London, England)
Thema
B5S3K2V0G8
31
COVID-19 Vaccines
31
ChAdOx1 nCoV-19
20
Journal Article
12
Research Support, Non-U.S. Gov't
11
Letter
10
BNT162 Vaccine
10
N38TVC63NU
8
Comment
8
Randomized Controlled Trial
6
Clinical Trial, Phase II
6
Vaccines
5
Antibodies, Viral
4
Immunoglobulin G
4
Multicenter Study
3
2019-nCoV Vaccine mRNA-1273
3
Antibodies, Neutralizing
3
EPK39PL4R4
3
Spike Glycoprotein, Coronavirus
2
Case Reports
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2022
24
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
31
Englisch
Haven't found what you're looking for?
Wird geladen...